PacificGMP Increases Production Capacity - - BioPharm International

ADVERTISEMENT

PacificGMP Increases Production Capacity



PacificGMP, a CMO, has doubled its GMP production capacity with the addition of a second System 1000 Bioreactor platform from GE Healthcare. This second System 1000, with a 500 L working volume, increases PacificGMP’s large scale GMP production capacity to 1000 L for fed and fed-batch production. In addition, it provides an additional 15,000 L of production capacity when run in perfusion mode. The addition provides PacificGMP a total perfusion capacity of 30,000 L.

Expansion of its operational capacity will allow PacificGMP to increase its large scale clinical manufacturing projects for its research clients, customers, and partners.

Source: PacificGMP

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines

Click here